Dong‐Wan Kim - Researcher Profile | RDL Research Database

Publications

2 shown

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Roy S. Herbst , Paul Baas , Dong‐Wan Kim +16 more

2015 The Lancet 6378 citations

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Sae‐Won Han , Tae‐You Kim , Pil Gyu Hwang +13 more

Purpose This study was undertaken to investigate the effects of epidermal growth factor receptor (EGFR) mutation and its downstream signaling on response and survival in non–sma...

2005 Journal of Clinical Oncology 775 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 7,153
Institution: Seoul National University Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-5124-7132

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.